Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry
Among women with PPCM, bromocriptine treatment in addition to standard of care was associated with better maternal outcomes after 6 months.
Authors
- Hasan Ali Farhan (ORCID: https://orcid.org/0000-0002-6061-4966)
- Sorel Goland (ORCID: https://orcid.org/0000-0002-5821-1113)
- Michael Böhm (ORCID: https://orcid.org/0000-0002-2976-2514)
- Mark C. Petrie (ORCID: https://orcid.org/0000-0002-6333-9496)
- Julian Hoevelmann (ORCID: https://orcid.org/0000-0002-2023-3026)
- Johann Bauersachs (ORCID: https://orcid.org/0000-0002-9341-117X)
- Karen S Sliwa (ORCID: https://orcid.org/0000-0002-8272-0911)
- Wouter Ouwerkerk (ORCID: https://orcid.org/0000-0002-2000-9358)
- Alice M. Jackson (ORCID: https://orcid.org/0000-0002-0364-1271)
- Denise Hilfiker‐Kleiner (ORCID: https://orcid.org/0000-0001-6065-9649)
- Bart J. van Essen (ORCID: https://orcid.org/0000-0002-9057-7449)
- Jasper Tromp (ORCID: https://orcid.org/0000-0001-6043-0713)
- Petar Seferović (ORCID: https://orcid.org/0000-0002-1955-4199)
- Alexandre Mebazaa (ORCID: https://orcid.org/0000-0001-8715-7753)
- Charle Viljoen (ORCID: https://orcid.org/0000-0001-7246-4136)
- Peter van der Meer (ORCID: https://orcid.org/0000-0002-9705-4413)
Institutions
- University Medical Center Groningen (NL)
- Serbian Academy of Sciences and Arts (RS)
- University of Baghdad (IQ)
- Inserm (FR)
- University of Cape Town (ZA)
- Philipps University of Marburg (DE)
- University of Groningen (NL)
- Université Paris Cité (FR)
- Hadassah Medical Center (IL)
- Kaplan Medical Center (IL)
- Groote Schuur Hospital (ZA)
- British Heart Foundation (GB)
- Medizinische Hochschule Hannover (DE)
- University of Belgrade (RS)
- Universitätsklinikum des Saarlandes (DE)
- Grade Medical (Czechia) (CZ)
- Hôpital Lariboisière (FR)
- Duke-NUS Medical School (SG)
- National Heart Centre Singapore (SG)
- National University Health System (SG)
- Amsterdam University Medical Centers (NL)
- Institute of Infection and Immunity (CA)
- University of Glasgow (GB)
- University of Amsterdam (NL)
- Saarland University (DE)
Publication Details
- Journal
- European Heart Journal
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1093/eurheartj/ehae559
- Citations
- 27
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 10.85
Funders
- Amgen
- Bristol-Myers Squibb
- ResMed Foundation
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Bayer
- Sanofi
- Edwards Lifesciences
- Boehringer Ingelheim
- Boston Scientific Corporation
- ResMed
- Gedeon Richter
- Servier
- Novartis Pharma
- Abbott Vascular
- European Research Council
- Daiichi Sankyo Europe